Alzheimer's disease

Do Eli Lilly and Biogen Have Alzheimer's All Wrong? Anavex Life Sciences Thinks So.
Motley Fool
Wed, 12/9/15 - 11:42 am
Eli Lilly
Biogen
Anavex
Alzheimer's disease
3 Leaders In Alzheimer's BACE Inhibition
Seeking Alpha
Wed, 12/2/15 - 11:05 am
Alzheimer's disease
Amgen
AstraZeneca
BACE inhibitors
Eli Lilly
Merck
Novartis
Prediction: A New Drug Will Soon Offer Hope in the Alzheimer’s Fight
Fortune
Tue, 12/1/15 - 01:12 pm
Eli Lilly
Alzheimer's disease
solanezumab
Lilly to Provide Detailed Review of Elanco Animal Health and Alzheimer's R&D Strategy at Investment Community Meeting
Yahoo
Fri, 11/20/15 - 10:42 am
Eli Lilly
Elanco
animal health
Alzheimer's disease
R&D
Former Biogen R&D Chief Emerges at $80M Startup Pursuing Cancer, Alzheimer's
Forbes
Tue, 11/17/15 - 09:11 am
Biogen
R&D
Alzheimer's disease
Codiak Biosciences
The FDA eases up on Forum's schizophrenia program with Alzheimer's trials still on hold
Fierce Biotech
Thu, 11/12/15 - 09:22 am
Forum Pharmaceuticals
FDA
schizophrenia
Alzheimer's disease
encenicline
Allergan counting on January formulary boost to jump-start Namzaric launch
Fierce Pharma Marketing
Wed, 11/11/15 - 09:54 am
Allergan
formulary
Namzaric
Alzheimer's disease
Aricept
Namenda
Eisai
Supreme Court asked to review Namenda product switching case
Pharmalot
Tue, 11/10/15 - 08:30 am
Supreme Court
Namenda
Namenda XR
Allergan
Alzheimer's disease
hard switch
A small biotech in a daunting field, Alzheon begins new Alzheimer’s study
Bizjournals.com
Fri, 11/6/15 - 10:40 am
Alzheon
Alzheimer's disease
ALZ-801
Glaxo, Pfizer, U.K. Form $100 Million Alzheimer's Research Fund
Bloomberg
Tue, 10/20/15 - 10:03 pm
GSK
Pfizer
UK
Alzheimer's disease
R&D
Advera Health Analytics: Novartis, Allergan Alzheimer's meds linked to abnormal behavior, blood pressure side effects
Fierce Pharma
Sun, 10/11/15 - 01:57 pm
Novartis
Allergan
Alzheimer's disease
Eisai
Exelon Patch
Namenda
Aricept
Why Cholesterol and Alzheimer’s Could Drive Eli Lilly Shares Much Higher
24/7 Wall St
Fri, 10/9/15 - 03:57 pm
Eli Lilly
solanezumab
evacetrapib
Alzheimer's disease
Company Run By 30-Year-Old Former Hedge Fund Manager Starts Study To Get Its Alzheimer's Drug Approved
Forbes
Tue, 10/6/15 - 08:12 am
Axovant Sciences
Alzheimer's disease
RVT-101
Sofinnova leads a $30.6M round for Asceneuron's Alzheimer's R&D
Fierce Biotech
Wed, 09/30/15 - 09:32 am
Asceneuron
Merck Serono
R&D
Alzheimer's disease
Embracing biotech, Nestlé recruits AC Immune for an Alzheimer's project
Fierce Biotech
Fri, 09/25/15 - 10:07 am
Alzheimer's disease
Nestle
AC Immune
R&D
Feds clamp a hold on Forum's PhIII Alzheimer's study following GI events
Fierce Biotech
Mon, 09/14/15 - 05:57 pm
Forum Pharmaceuticals
Alzheimer's disease
encenicline
FDA
Novartis to Work With Amgen on Alzheimer’s and Migraine Drugs
Bloomberg
Wed, 09/2/15 - 10:18 am
Novartis
Amgen
migraines
Alzheimer's disease
R&D
CNP520
AMG 334
Here's Why Biogen Lost $20 Billion in Market Value in July
Motley Fool
Thu, 08/6/15 - 08:34 am
Biogen
aducanumab
Alzheimer's disease
Lilly to End Contract with the University of California, San Diego for A4 Alzheimer's Study
Yahoo
Wed, 08/5/15 - 09:00 am
R&D
Eli Lilly
Alzheimer's disease
Another Alzheimer's IPO
Seeking Alpha
Fri, 07/31/15 - 11:12 am
Alzheimer's disease
azeliragon
vTv Therapeutics

Pages